MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL)

CUSIP: 558868105

Q3 2018 13F Holders as of 30 Sep 2018

Holder snapshot 7 signals
Share change
+505,873
Put/Call ratio
24%
SEC-reported price per share
$214.13
Number of holders
153
Value change
+$62,737,488
Number of buys
93
Open additional details 1 more signal available
Number of sells
72
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
22,822,754

Security key

558868105

Report period

Q3 2018

Institutions

153

Top holders

10

Ownership snapshot

Top reported holders of MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Capital Research Global I...
Disclosed value leader
Capital Research Global I...
Comparable rows
15/15
Latest evidence
30 Jun 2018
13F Lead comparable stake: 6% Showing 1-6 of 15 holder rows.

Quick read

Capital Research Global Investors leads the comparable SEC ownership view at 6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Capital Research Global Investors's linked filing trail.
Comparable ownership Top 5
Capital Research Global Investors 6%
BAKER BROS. ADVISORS LP 5.1%
PRICE T ROWE ASSOCIATES INC /MD/ 2.5%
Avoro Capital Advisors LLC 2.1%
BlackRock Finance, Inc. 2.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Capital Research Global Investors
13F
Company
13F
6%
$383,246,000
1,370,252 shares
30 Jun 2018
BAKER BROS. ADVISORS LP
13F
Company
13F
5.1%
$327,035,000
1,169,278 shares
30 Jun 2018
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
2.5%
$158,900,000
568,128 shares
30 Jun 2018
Avoro Capital Advisors LLC
13F
Company
13F
2.1%
$136,918,000
489,536 shares
30 Jun 2018
BlackRock Finance, Inc.
13F
Company
13F
2.1%
$136,627,000
488,499 shares
30 Jun 2018
VANGUARD GROUP INC
13F
Company
13F
2%
$129,400,000
462,654 shares
30 Jun 2018
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
153
Shares
8,620,856
Rows available
153
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2018 vs Q2 2018 Across Filers

Q2 2018 holders
148
Q3 2018 holders
153
Holder diff
5
Investor Q2 2018 Shares Q3 2018 Shares Share Diff Share Chg % Q2 2018 value Q3 2018 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .